ch.oddb.org
 
Analyses | Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation - 30
66808001 GlaxoSmithKline AG
Trelegy Ellipta, Einzeldosiertes Pulver zur Inhalation20.09.2018
  20.09.2018
Vilanterol, Umeclidinium Bromide and Fluticasone Furoate (R03AL08) 
WHO-DDD19.09.2023
03.99.30
03.99. 
B  
YesCOPD
IP 
68.44Yes
    
10 %94.95
  
7680668080014Synthetika
  
Composition
fluticasoni furoas 100 µg, umeclidinium 62.5 µg ut umeclidinii bromidum, vilanterolum 25 µg ut vilanteroli trifenatas, excipiens ad pulverem pro dosi.
Packungsbestandteile
Einzeldosiertes Pulver zur Inhalation
Excipiens ad Pulverem pro Dosi
 
Active AgentDose
Fluticasoni Furoas100 µg
Umeclidinium62.5 µg
Vilanterolum25 µg
Source
Data was imported : 03.10.2018
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
 
2019 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home